NCT02002741View on ClinicalTrials.gov

Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 1, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

December 31, 2017

Conditions
Ductus Arteriosus, Patent
Interventions
DRUG

Paracetamol

Ibuprofen 3 doses administered q24h + Paracetamol 12 doses administered q 6h

DRUG

Placebo

Ibuprofen 3 doses administered q24h + Placebo : 12 doses administered q 6h

Trial Locations (1)

31096

Rambam Medical Center, Haifa

All Listed Sponsors
lead

Rambam Health Care Campus

OTHER

NCT02002741 - Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants | Biotech Hunter | Biotech Hunter